0001062993-23-016714.txt : 20230817 0001062993-23-016714.hdr.sgml : 20230817 20230817162024 ACCESSION NUMBER: 0001062993-23-016714 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230815 FILED AS OF DATE: 20230817 DATE AS OF CHANGE: 20230817 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kelderman Kim CENTRAL INDEX KEY: 0001739054 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 231182170 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2023-08-15 0000842023 BIO-TECHNE Corp TECH 0001739054 Kelderman Kim 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413 0 1 0 0 Pres. Diagnostics & Genom 0 Common Stock 19125 D Stock Option (Right to Buy) 37.70 2025-05-01 Common Stock 27392 27392 D Stock Option (Right to Buy) 44.33 2025-08-08 Common Stock 48176 48176 D Stock Option (Right to Buy) 44.33 2025-08-08 Common Stock 36132 36132 D Stock Option (Right to Buy) 47.60 2026-08-07 Common Stock 47844 47844 D Stock Option (Right to Buy) 47.60 2026-08-07 Common Stock 63792 63792 D Stock Option (Right to Buy) 66.97 2027-08-05 Common Stock 35964 35964 D Stock Option (Right to Buy) 66.97 2027-08-05 Common Stock 33300 33300 D Restricted Stock Units Common Stock 8060 0 D Stock Option (Right to Buy) 66.97 2027-08-05 Common Stock 47952 47952 D Restricted Stock Units Common Stock 4980 4980 D Stock Option (Right to Buy) 120.46 2028-08-06 Common Stock 19456 19456 D Stock Option (Right to Buy) 120.46 2028-08-06 Common stock 25944 25944 D Restricted Stock Units Common Stock 6984 6984 D Stock Options (Right to Buy) 94.52 2029-08-15 Common Stock 21704 21704 D Stock Options (Right to Buy) 94.52 2029-08-15 Common Stock 28940 28940 D Restricted Stock Units 2023-08-15 4 A 0 8191 0 A Common Stock 8191 8191 D Stock Options (Right to Buy) 84.61 2023-08-15 4 A 0 22043 0 A 2030-08-15 Common Stock 22043 22043 D Stock Options (Right to Buy) 84.61 2023-08-15 4 A 0 29391 0 A 2030-08-15 Common Stock 29391 29391 D Fully exercisable. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. On 8/5/2023, the Board of Directors certified vesting of 8,060 performance RSUs. Options to purchase 11,988 shares vest on each of 8/5/2021, 8/5/2022, 8/5/2023 and 8/5/2024. Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 12,972 shares are vested. Options to purchase 6,488 shares vest on 8/6/2024 and options to purchase 6,484 shares vest on 8/6/2025. Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 7,236 shares vest on each of 8/15/2023, 8/15/2024 and 8/15/2026 and options to purchase 7,232 shares vest on 8/15/2025. Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026. /s/ Andrew Nick, Attorney-in-Fact for Kim Kelderman pursuant to Power of Attorney previously filed. 2023-08-17